Deanna L. Kelly

9.9k total citations · 1 hit paper
208 papers, 6.5k citations indexed

About

Deanna L. Kelly is a scholar working on Psychiatry and Mental health, Clinical Psychology and Pharmacology. According to data from OpenAlex, Deanna L. Kelly has authored 208 papers receiving a total of 6.5k indexed citations (citations by other indexed papers that have themselves been cited), including 103 papers in Psychiatry and Mental health, 30 papers in Clinical Psychology and 26 papers in Pharmacology. Recurrent topics in Deanna L. Kelly's work include Schizophrenia research and treatment (94 papers), Bipolar Disorder and Treatment (36 papers) and Tryptophan and brain disorders (24 papers). Deanna L. Kelly is often cited by papers focused on Schizophrenia research and treatment (94 papers), Bipolar Disorder and Treatment (36 papers) and Tryptophan and brain disorders (24 papers). Deanna L. Kelly collaborates with scholars based in United States, South Korea and France. Deanna L. Kelly's co-authors include Robert R. Conley, Robert P. McMahon, Raymond C. Love, Robert W. Buchanan, Douglas L. Boggs, Julie Kreyenbuhl, Stephanie Feldman, Heidi J. Wehring, Nicola G. Cascella and Alessio Fasano and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Advanced Functional Materials.

In The Last Decade

Deanna L. Kelly

203 papers receiving 6.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The 2009 Schizophrenia PORT Psychopharmacological Treatment Recommendations and Summary Statements

2009 685 citations Robert W. Buchanan, Deanna L. Kelly et al. Schizophrenia Bulletin profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Deanna L. Kelly United States	41	3.2k	1.1k	966	816	751	208	6.5k
James H. MacCabe United Kingdom	46	4.6k 1.4×	532 0.5×	1.6k 1.6×	595 0.7×	884 1.2×	219	7.6k
Gerhard Hellemann United States	49	4.0k 1.2×	698 0.7×	2.3k 2.3×	494 0.6×	629 0.8×	193	8.4k
Chunbo Li China	43	3.7k 1.1×	559 0.5×	1.4k 1.5×	550 0.7×	596 0.8×	326	8.3k
Michele Fornaro Italy	49	3.9k 1.2×	1.3k 1.2×	2.3k 2.4×	640 0.8×	1.5k 2.0×	244	8.8k
James B. Lohr United States	50	2.6k 0.8×	406 0.4×	1.2k 1.2×	870 1.1×	790 1.1×	139	7.1k
Michael Riedel Germany	52	3.5k 1.1×	1.2k 1.1×	1.3k 1.3×	1.8k 2.2×	2.5k 3.3×	219	9.7k
Eugenio Aguglia Italy	41	2.5k 0.8×	876 0.8×	1.8k 1.9×	358 0.4×	629 0.8×	218	6.1k
Takefumi Suzuki Japan	37	2.6k 0.8×	797 0.7×	766 0.8×	551 0.7×	310 0.4×	234	4.6k
Domenico De Berardis Italy	52	2.9k 0.9×	1.2k 1.1×	2.5k 2.6×	448 0.5×	1.3k 1.7×	281	7.7k
W. Wolfgang Fleischhacker Austria	64	7.2k 2.2×	1.2k 1.2×	2.1k 2.1×	720 0.9×	755 1.0×	266	11.1k

Countries citing papers authored by Deanna L. Kelly

Since Specialization

Citations

This map shows the geographic impact of Deanna L. Kelly's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Deanna L. Kelly with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Deanna L. Kelly more than expected).

Fields of papers citing papers by Deanna L. Kelly

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Deanna L. Kelly. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Deanna L. Kelly. The network helps show where Deanna L. Kelly may publish in the future.

Co-authorship network of co-authors of Deanna L. Kelly

This figure shows the co-authorship network connecting the top 25 collaborators of Deanna L. Kelly. A scholar is included among the top collaborators of Deanna L. Kelly based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Deanna L. Kelly. Deanna L. Kelly is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Vyas, Gopal, Daniel Roche, Heather A. Adams, et al.. (2025). Case Report: Metabolic, inflammatory, and neurological improvements after a ketogenic diet in a woman with treatment-resistant schizophrenia and metabolic syndrome. Frontiers in Psychiatry. 16. 1710785–1710785.

Kim, Eunkyoung, Mijeong Kang, Deanna L. Kelly, et al.. (2025). Electrochemistry as a Tool for Redox‐Based Bio‐Information Processing. Advanced Science. 12(36). e10184–e10184.

Dewan, Mantosh, Jeffrey Hunt, Deanna L. Kelly, et al.. (2024). Aberrant salience signaling in auditory processing in schizophrenia: Evidence for abnormalities in both sensory processing and emotional reactivity. Schizophrenia Research. 274. 329–336. 1 indexed citations

Kim, Eunkyoung, Fang Liu, Daniel Roche, et al.. (2024). Pilot study indicates that a gluten-free diet lowers oxidative stress for gluten-sensitive persons with schizophrenia. Schizophrenia Research. 269. 71–78. 5 indexed citations

Powell, Megan, Heather A. Adams, Elaine Weiner, et al.. (2022). 25-Hydroxyvitamin D and metabolic-related laboratory values in women with schizophrenia and hyperprolactinemia. Journal of Psychiatric Research. 151. 25–29. 2 indexed citations

Johnson, Kirk W., et al.. (2021). Levels of prolactin and testosterone and associated sexual dysfunction and breast abnormalities in men with schizophrenia treated with antipsychotic medications. Journal of Psychiatric Research. 143. 50–53. 16 indexed citations

Schoretsanitis, Georgios, John M. Kane, Christoph U. Correll, et al.. (2020). Blood Levels to Optimize Antipsychotic Treatment in Clinical Practice. The Journal of Clinical Psychiatry. 81(3). 88 indexed citations

Wehring, Heidi J., et al.. (2019). Effects of Cigarette Smoking and Clozapine Treatment on 20-Year All-Cause & Cardiovascular Mortality in Schizophrenia. Psychiatric Quarterly. 90(2). 351–359. 13 indexed citations

Kelly, Deanna L. & Raymond C. Love. (2019). Psychiatric pharmacist's role in overcoming barriers to clozapine use and improving management. Mental Health Clinician. 9(2). 64–69. 9 indexed citations

10.

Kelly, Deanna L., et al.. (2019). Clozapine-associated renal failure: A case report and literature review. Mental Health Clinician. 9(3). 124–127. 4 indexed citations

11.

Warren, Kimberly R., Heidi J. Wehring, Fang Liu, et al.. (2018). Effects of intranasal oxytocin on satiety signaling in people with schizophrenia. Physiology & Behavior. 189. 86–91. 6 indexed citations

12.

Rubin, Leah H., Haley K. Demyanovich, Heidi J. Wehring, et al.. (2017). M27. Peripheral Oxytocin and Vasopressin are Associated With Clinical Symptom Severity and Cognitive Functioning in Midlife Women With Chronic Schizophrenia. Schizophrenia Bulletin. 43(suppl_1). S221–S221. 2 indexed citations

13.

Okusaga, Olaoluwa, Dietmar Fuchs, Gloria Reeves, et al.. (2016). Kynurenine and Tryptophan Levels in Patients With Schizophrenia and Elevated Antigliadin Immunoglobulin G Antibodies. Psychosomatic Medicine. 78(8). 931–939. 21 indexed citations

14.

Zheng, Wei, Shi-Bin Wang, Xin-Hu Yang, et al.. (2016). Adjunctive minocycline for schizophrenia: A meta-analysis of randomized controlled trials. European Neuropsychopharmacology. 27(1). 8–18. 65 indexed citations

15.

Jackson, Jessica, William W. Eaton, Nicola G. Cascella, et al.. (2014). Gluten sensitivity and relationship to psychiatric symptoms in people with schizophrenia. Schizophrenia Research. 159(2-3). 539–542. 25 indexed citations

16.

Abrams, Michael T., Carol S. Myers, Stephanie Feldman, et al.. (2012). Cervical Cancer Screening and Acute Care Visits Among Medicaid Enrollees With Mental and Substance Use Disorders. Psychiatric Services. 63(8). 815–822. 32 indexed citations

17.

Kelly, Deanna L., et al.. (2009). Nonresponse to clozapine and premorbid functioning in treatment refractory schizophrenia. Comprehensive Psychiatry. 51(3). 298–302. 10 indexed citations

18.

McMahon, Robert P., Deanna L. Kelly, Douglas L. Boggs, et al.. (2008). Feasibility of Reducing the Duration of Placebo-Controlled Trials in Schizophrenia Research. Schizophrenia Bulletin. 34(2). 292–301. 23 indexed citations

19.

Kelly, Deanna L., Robert R. Conley, Stephanie Feldman, et al.. (2006). Adjunct Divalproex or Lithium to Clozapine in Treatment-Resistant Schizophrenia. Psychiatric Quarterly. 77(1). 81–95. 55 indexed citations

20.

Kelly, Deanna L., et al.. (2004). Atypical Antipsychotic Use in a State Hospital Inpatient Adolescent Population. Journal of Child and Adolescent Psychopharmacology. 14(1). 75–85. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact